Head to Head Survey: ACI Global (OTCMKTS:ACGJ) and Viridian Therapeutics (NASDAQ:VRDN)

ACI Global (OTCMKTS:ACGJ) and Viridian Therapeutics (NASDAQ:VRDN) are both industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk.

Analyst Recommendations

This is a summary of current ratings and target prices for ACI Global and Viridian Therapeutics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ACI Global	0	0	0	0	0.00
Viridian Therapeutics	0	3	9	0	2.75

Viridian Therapeutics has a consensus target price of $35.70, suggesting a potential upside of 147.23%. Given Viridian Therapeutics’ stronger consensus rating and higher probable upside, analysts plainly believe Viridian Therapeutics is more favorable than ACI Global.

Earnings and Valuation

This table compares ACI Global and Viridian Therapeutics”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ACI Global	N/A	N/A	N/A	N/A	N/A
Viridian Therapeutics	$302,000.00	3,896.17	-$237.73 million	($3.77)	-3.83

ACI Global has higher earnings, but lower revenue than Viridian Therapeutics.

Profitability

This table compares ACI Global and Viridian Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ACI Global	N/A	N/A	N/A
Viridian Therapeutics	-85,127.16%	-70.12%	-41.49%

Volatility & Risk

ACI Global has a beta of 2.12, meaning that its share price is 112% more volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500.

About ACI Global

ACI Global Corporation, a development stage company, through its subsidiaries, engages in the design and development of proprietary technology for the production of synthetic rubber powder and thermoplastic elastomers under Micropowder trade name in the United States. It intends to utilize Micropowder technology in its chemical composition and for the manufacture of rubber and elastomers that are used in tire plastic industries. ACI Global was founded in 1997 and is based in Greenwich, Connecticut.

About Viridian Therapeutics

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.